The A-share innovative drug sector continued to strengthen, with Wanbang Pharmaceutical hitting the 20% daily limit up, Shuanglu Pharmaceutical, Kangyuan Pharmaceutical, and Kailaiying hitting the 10% daily limit up, Hengrui Medicine rising more than

2026-06-29

The A-share innovative drug sector continued to strengthen, with Wanbang Pharmaceutical hitting the 20% daily limit up, Shuanglu Pharmaceutical, Kangyuan Pharmaceutical, and Kailaiying hitting the 10% daily limit up, Hengrui Medicine rising more than 8%, and WuXi AppTec, Changshan Pharmaceutical, and others following suit.